(Q43729839)

English

Biomonitoring of urinary tamoxifen and its metabolites from breast cancer patients using nonaqueous capillary electrophoresis with electrospray mass spectrometry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Biomonitoring of urinary tamoxifen and its metabolites from breast cancer patients using nonaqueous capillary electrophoresis with electrospray mass spectrometry (English)

1 reference

Europe PubMed Central

26 November 2017

electrophoresis

0 references

tamoxifen N-oxide

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

author name string

Carter SJ

1

1 reference

Europe PubMed Central

26 November 2017

Li XF

2

1 reference

Europe PubMed Central

26 November 2017

Mackey JR

3

1 reference

Europe PubMed Central

26 November 2017

Modi S

4

1 reference

Europe PubMed Central

26 November 2017

Hanson J

5

1 reference

Europe PubMed Central

26 November 2017

Dovichi NJ

6

1 reference

Europe PubMed Central

26 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

26 November 2017

Electrophoresis

1 reference

Europe PubMed Central

26 November 2017

22

1 reference

Europe PubMed Central

26 November 2017

13

1 reference

Europe PubMed Central

26 November 2017

2730-2736

1 reference

Europe PubMed Central

26 November 2017

The pharmacology and clinical uses of tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Use of tamoxifen for breast cancer: twenty-eight years later

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Tamoxifen in postmenopausal women a safety perspective

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Breast cancer prevention by antiestrogens

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Peptide antagonists of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Identification of estrogenic tamoxifen metabolite(s) in tamoxifen-resistant human breast tumors

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Tamoxifen metabolic patterns within a glioma patient population treated with high-dose tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen.

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Detecting amino acids on Mars

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Analysis of lipophilic peptides and therapeutic drugs: on-line-nonaqueous capillary electrophoresis-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Tamoxifen metabolism: pharmacokinetic and in vitro study

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Acquired tamoxifen resistance in human breast cancer--potential mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Solid Phase Extraction and High Performance Liquid Chromatography of Tamoxifen and Its Demethylated Metabolites in Plasma

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Improved electrospray ionization interface for capillary zone electrophoresis-mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Reduced tamoxifen accumulation is not associated with stimulated growth in tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levels

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Determination of tamoxifen and metabolites in human serum by high-performance liquid chromatography with post-column fluorescence activation

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Paired-ion chromatographic analysis of tamoxifen and two major metabolites in plasma

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Quantification of tamoxifen and N-desmethyltamoxifen in human plasma by high-performance liquid chromatography, photochemical reaction and fluorescence detection, and its application to biopharmaceutic investigations

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Determination of tamoxifen and five metabolites in plasma

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

High-performance liquid chromatographic analysis of tamoxifen and major metabolites in human plasma

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Analysis of tamoxifen and its metabolites in human plasma by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM)

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Identification and mechanism of formation of potentially genotoxic metabolites of tamoxifen: study by LC-MS/MS

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Analysis of tamoxifen and its metabolites by on-line capillary electrophoresis-electrospray ionization mass spectrometry employing nonaqueous media containing surfactants

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Effect of electrolyte and solvent composition on capillary electrophoretic separation of some pharmaceuticals in non-aqueous media

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

On-line nonaqueous capillary electrophoresis and electrospray mass spectrometry of tricyclic antidepressants and metabolic profiling of amitriptyline byCunninghamella elegans

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Optimised separation of E- and Z- isomers of tamoxifen, and its principal metabolites using reversed-phase high performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

HPLC analysis of creatinine in human plasma and urine

1 reference

https://api.crossref.org/works/10.1002%2F1522-2683%28200108%2922%3A13%3C2730%3A%3AAID-ELPS2730%3E3.0.CO%3B2-3

21 January 2018

Identifiers

10.1002/1522-2683(200108)22:13<2730::AID-ELPS2730>3.0.CO;2-3

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43729839&oldid=2102887880"